Cryoprecipitate utilization in the neonatal intensive care unit: a single-center review
- 8 June 2026
- journal article
- Published by Springer Nature in Journal of Perinatology
Abstract
Significant variability exists in the indications for and dosing of cryoprecipitate transfusions. We examined cryoprecipitate transfusions in neonates with a focus on indications, dosing, and the incidence of multi-donor exposure. In this retrospective study, cryoprecipitate transfusions administered in a single neonatal intensive care unit from January 2022 to December 2024 were reviewed. Patient characteristics, diagnoses, laboratory values, and transfusion details were collected. In total, 50 patients received 104 cryoprecipitate transfusions. The median pre-transfusion fibrinogen level was 100 mg/dL (range 15-586), the median dose was 5.9 mL/kg (range 2.1-16.2), and the median increase in fibrinogen was 115 mg/dL (range -5 to 513). Based on the volume administered, 30% of transfusions likely resulted in multi-donor exposure, with no significant difference in the post-transfusion fibrinogen level achieved. Significant variation in cryoprecipitate transfusion practices exist, even within a single center. Increasing the weight-based dose of transfusion increases multi-donor exposure without significant clinical benefit.Keywords
This publication has 20 references indexed in Scilit:
- Pathogen-Reduce CryoprecipitateClinics In Laboratory Medicine, 2025
- Fresh frozen plasma and cryoprecipitate: Can we safely reduce their use in the NICU?Journal of Perinatology, 2022
- Pediatric Hemovigilance and Adverse Transfusion ReactionsClinics In Laboratory Medicine, 2021
- Coagulation standards in healthy newborns and infantsArchives de Pédiatrie, 2021
- Review of current transfusion therapy and blood banking practicesBlood Reviews, 2019
- Fibrinogen is an independent predictor of mortality in major trauma patients: A five-year statewide cohort studyInjury, 2017
- Cryoprecipitate therapyBritish Journal of Anaesthesia, 2014
- Platelets, Frozen Plasma, and Cryoprecipitate: What is the Clinical Evidence for Their Use in the Neonatal Intensive Care Unit?Seminars in Perinatology, 2009
- Decreasing blood donor exposure in the neonates by using dedicated donor transfusionsTransfusion Science, 1997
- Development of the Hemostatic System in the Neonate and Young InfantJournal of Pediatric Hematology/Oncology, 1990